01:58Senator finds GSK profited by pulling kids' asthma inhaler
From the creator
In 2024, doctors and parents scrambled to find an affordable asthma inhaler after drugmaker GSK pulled the popular Flovent off the market. A senator launched an investigation to find out what happened, sharing her findings exclusively with CNN. #news #cnn
Published 2026-03-16 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.





